It also includes the Fountain Report, an executive focused comprehensive weekly newsletter read by
animal health industry executives.
Not exact matches
As Chairman, Schwichtenberg presides over all meetings of the Board of Directors, the governing body of APPA.She also serves in a leadership advisory role guiding APPA's
industry - wide activities.Schwichtenberg previously served as Vice Chairman of the Board for APPA.Schwichtenberg is the President and Chief
Executive Officer of the Central Garden & Pet strategic business unit Central Life Sciences.Specializing in the development, manufacturing and marketing of category - leading product brands such as Farnam, Zodiac, Bio Spot, Horse
Health Products, Adams, PreStrike and Platform Feeds, Central Life Sciences focuses on improving the quality of life for companion animals.Prior to Central Life Sciences, Schwichtenberg was Vice President and general manager of the Consumer Animal Health Division of Sandoz, Inc. (now Novartis, Inc.), a worldwide leader in human pharmaceuticals and animal health pro
Health Products, Adams, PreStrike and Platform Feeds, Central Life Sciences focuses on improving the quality of life for companion animals.Prior to Central Life Sciences, Schwichtenberg was Vice President and general manager of the Consumer
Animal Health Division of Sandoz, Inc. (now Novartis, Inc.), a worldwide leader in human pharmaceuticals and animal health pro
Animal Health Division of Sandoz, Inc. (now Novartis, Inc.), a worldwide leader in human pharmaceuticals and animal health pro
Health Division of Sandoz, Inc. (now Novartis, Inc.), a worldwide leader in human pharmaceuticals and
animal health pro
animal health pro
health products.
«Fran is recognized in the
health care industry for being both a visionary leader and a strategic entrepreneur, with a track record for bringing out the best in people to drive growth and business excellence,» said Lonnie Shoff, Chief Executive Officer, Global Animal Health and Strategic Partnership
health care
industry for being both a visionary leader and a strategic entrepreneur, with a track record for bringing out the best in people to drive growth and business excellence,» said Lonnie Shoff, Chief
Executive Officer, Global
Animal Health and Strategic Partnership
Health and Strategic Partnership Group.
Stanley M. Bergman, Chairman of the Board and Chief
Executive Officer of Henry Schein, Inc., delivered the summit's keynote address, discussing key trends impacting technology and the
animal health industry.
«The acquisition demonstrates our determination to lead the
animal health industry in the development and commercialization of monoclonal antibody therapies in areas of high medical need,» said Alejandro Bernal, DVM, MS, MBA, an
executive vice president and group president a Zoetis.
Prior to founding Genesis, he spent 15 years in the human medical device and
animal health industries, including executive positions with Medex Medical, the All - Care Animal Referral Center (a specialty referral veterinary hospital) and AnaMed International, and was Director of Sales & Marketing for Marquest Medical Pro
animal health industries, including
executive positions with Medex Medical, the All - Care
Animal Referral Center (a specialty referral veterinary hospital) and AnaMed International, and was Director of Sales & Marketing for Marquest Medical Pro
Animal Referral Center (a specialty referral veterinary hospital) and AnaMed International, and was Director of Sales & Marketing for Marquest Medical Products.
«The
industry - leading companies that form the AVDA understand the importance of the human -
animal bond and how it enhances both human and
animal health,» said HABRI
executive director Steven Feldman.
Howard C London has been in the pet and
animal health industries for 25 - plus years, as a retail - chain owner, sales and marketing
executive, and business owner.